AARTI PHARMALABS
|
AARTI PHARMALABS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Profit Before Tax | ₹300 Cr | ₹261 Cr | ₹155 Cr | ₹0.00 Cr |
Adjustment | ₹95 Cr | ₹83 Cr | ₹52 Cr | - |
Changes In working Capital | ₹-122 Cr | ₹-32 Cr | ₹-230 Cr | ₹0.00 Cr |
Cash Flow after changes in Working Capital | ₹273 Cr | ₹312 Cr | ₹-23 Cr | - |
Cash Flow from Operating Activities | ₹216 Cr | ₹250 Cr | ₹-44 Cr | - |
Cash Flow from Investing Activities | ₹-215 Cr | ₹-158 Cr | ₹-139 Cr | - |
Cash Flow from Financing Activities | ₹9.72 Cr | ₹-163 Cr | ₹260 Cr | - |
Net Cash Inflow / Outflow | ₹12 Cr | ₹-71 Cr | ₹78 Cr | - |
Opening Cash & Cash Equivalents | ₹12 Cr | ₹83 Cr | ₹5.33 Cr | ₹0.25 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - |
Closing Cash & Cash Equivalent | ₹24 Cr | ₹12 Cr | ₹83 Cr | ₹0.25 Cr |
Compare Cashflow Statement of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹6,827.6 Cr | 2.9% | 2.7% | 73% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,941.5 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 2.9% |
2.7% |
73% |
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses